CCMB Director Vinay Kumar Nandicoori and IICT Director D. Srinivas Reddy at a press conference held in Hyderabad on Wednesday (April 16, 2025)
| Photo Credit: BY ARRANGEMENT
CSIR-Indian Institute of Chemical Technology (IICT) and CSIR-Centre for Cellular and Molecular Biology (CCMB) are working on ‘Anti-Viral Mission’ to come up with drugs and diagnostics to deal with potential emerging viruses in the near future.
CCMB Director Vinay Kumar Nandicoori and IICT Director D. Srinivas Reddy at a press conference held in Hyderabad on Wednesday (April 16, 2025) said that the scientific collaboration is not only to repurpose the existing anti-viral drugs but also to come out with new molecules which would lead to better therapeutics.
The top scientists also explained that the joint research between both the premier labs had also helped in repurposing drug treatment for the sickle cell anaemia.
The Atal Incubation Centre (AIC)-CCMB is also involved in finding out mRNA vaccines technology’s – developed indigenously by its researchers for a potential vaccine against SARS-CoV-2 (COVID) – use against other infectious diseases like Tuberculosis (TB), Chikungunya and Japanese Encephalitis.
Science Corridor in Hyderabad
Funding has been received for few other research projects jointly being taken up by researchers from both the labs located adjacent to each other on the Tarnaka-Habsiguda road [in Hyderabad] which is proposed to be taken up as a ‘Science Corridor’ with the help of Hyderabad Metro Rail, they added.
Published – April 16, 2025 05:23 pm IST